AI assistant
Sending…
Ocugen, Inc. — Director's Dealing 2021
Oct 27, 2021
32915_dirs_2021-10-27_32fe9661-c000-4d2f-a735-a99c537c4c35.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Ocugen, Inc. (OCGN)
CIK: 0001372299
Period of Report: 2021-10-26
Reporting Person: Subramanian Sanjay (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-10-26 | Common Stock | S | 10000 | $11.07 | Disposed | 35591 | Direct |
Footnotes
F1: This sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
More from Ocugen, Inc.
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 24
Regulatory Filings
2026
Mar 20
Annual Report
2026
Mar 4
Regulatory Filings
2026
Mar 4